The impact of uterine adenomyosis on the histopathological risk factors and survival in patients with endometrial adenocarcinoma

References

• Aslan K, Sarı ME, Yalçın HR, Yalçın İ, Cüylan ZFi, Özdal B. 2020. Coexistence of uterine adenomyosis is not associated with a better prognosis in endometrioid-type endometrial cancer. Irish Journal of Medical Science 189:835–842.
   PubMed Web of Science ®Google Scholar
• Barlin JN, Zhou Q, St. Clair CM, Iasonos A, Soslow RA, Alektiar KM, et al. 2013. Classification and regression tree (CART) analysis of endometrial carcinoma: seeing the forest for the trees. Gynecologic Oncology 130:452–456.
   PubMed Web of Science ®Google Scholar
• Bendifallah S, Canlorbe G, Raimond E, Hudry D, Coutant C, Graesslin O, et al. 2014. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion. British Journal of Cancer 110:2640–2646.
   PubMed Web of Science ®Google Scholar
• Bergholt T, Eriksen L, Berendt N, Jacobsen M, Hertz JB. 2001. Prevalence and risk factors of adenomyosis at hysterectomy. Human Reproduction (Oxford, England) 16:2418–2421.
   PubMed Web of Science ®Google Scholar
• Bokhman JV. 1983. Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology 15:10–17.
   PubMed Web of Science ®Google Scholar
• Boonlak S, Aue-Aungkul A, Kietpeerakool C, Kleebkaow P, Chumworathayi B, Luanratanakorn S, et al. 2019. Impact of coexisting uterine adenomyosis on the survival outcome of patients with endometrial cancer: a retrospective cohort study. Asian Pacific Journal of Cancer Prevention 20:1185–1190.
   PubMedGoogle Scholar
• Chao X, Wu M, Ma S, Tan X, Zhong S, Bi Y, et al. 2020. The clinicopathological characteristics and survival outcomes of endometrial carcinoma coexisting with or arising in adenomyosis: a pilot study. Scientific Reports 10:5984.
   PubMed Web of Science ®Google Scholar
• Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. 2016. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. International Journal of Gynecological Cancer 26:2–30.
   PubMed Web of Science ®Google Scholar
• Erkilinç S, Taylan E, Gülseren V, Erkilinç G, Karadeniz T, Bağci M, et al. 2018. The effect of adenomyosis in myometrial invasion and overall survival in endometrial cancer. International Journal of Gynecological Cancer 28:145–151.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer 136:E359–386.
   PubMed Web of Science ®Google Scholar
• Gizzo S, Patrelli TS, Dall'asta A, DI Gangi S, Giordano G, Migliavacca C, et al. 2016. Coexistence of adenomyosis and endometrioid endometrial cancer: role in surgical guidance and prognosis estimation. Oncology Letters 11:1213–1219.
   PubMed Web of Science ®Google Scholar
• Goebel EA, Vidal A, Matias-Guiu X, Blake Gilks C. 2018. The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future. Virchows Archiv: An International Journal of Pathology 472:885–896.
   PubMed Web of Science ®Google Scholar
• Habiba M, Pluchino N, Petignat P, Bianchi P, Brosens IA, Benagiano G. 2018. Adenomyosis and endometrial cancer: literature review. Gynecologic and Obstetric Investigation 83:313–328.
   PubMed Web of Science ®Google Scholar
• Hertlein L, Rath J, Zeder-Göss C, Fürst S, Bayer D, Trillsch F, et al. 2017. Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only. Oncology Letters 14:3302–3308.
   PubMed Web of Science ®Google Scholar
• Hever A, Roth RB, Hevezi PA, Lee J, Willhite D, White EC, et al. 2006. Molecular characterization of human adenomyosis. Molecular Human Reproduction 12:737–748.
   PubMed Web of Science ®Google Scholar
• Koike N, Tsunemi T, Uekuri C, Akasaka J, Ito F, Shigemitsu A, et al. 2013. Pathogenesis and malignant transformation of adenomyosis (review). Oncology Reports 29:861–867.
   PubMed Web of Science ®Google Scholar
• Machida H, Maeda M, Cahoon SS, Scannell CA, Garcia-Sayre J, Roman LD, et al. 2017. Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities? Archives of Gynecology and Obstetrics 295:1459–1468.
   PubMed Web of Science ®Google Scholar
• Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. 2000. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? American Journal of Obstetrics and Gynecology 182:1506–1519.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Cahoon SS, Gualtieri M, Scannell CA, Jung CE, Takano T, et al. 2014. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer. Annals of Surgical Oncology 21:4246–4255.
   PubMed Web of Science ®Google Scholar
• Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. 2016. Endometrial cancer. Lancet (London, England) 387:1094–1108.
   PubMed Web of Science ®Google Scholar
• Musa F, Frey MK, Im HB, Chekmareva M, Ellenson LH, Holcomb K. 2012. Does the presence of adenomyosis and lymphovascular space invasion affect lymph node status in patients with endometrioid adenocarcinoma of the endometrium? American Journal of Obstetrics and Gynecology 207:417.e1–417.e6.
   PubMed Web of Science ®Google Scholar
• Pecorelli S. 2009. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynaecology and Obstetrics 105:103–104.
   PubMed Web of Science ®Google Scholar
• Raffone A, Seracchioli R, Raimondo D, Maletta M, Travaglino A, Raimondo I, et al. 2021. Prevalence of adenomyosis in endometrial cancer patients: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics 303:47–53.
   PubMed Web of Science ®Google Scholar
• Roddy E, Chapman J. 2017. Genomic insights in gynecologic cancer. Current Problems in Cancer 41:8–36.
   PubMed Web of Science ®Google Scholar
• Santoro A, Angelico G, Travaglino A, Inzani F, Arciuolo D, Valente M, et al. 2021. New pathological and clinical insights in endometrial cancer in view of the updated ESGO/ESTRO/ESP guidelines. Cancers 13:2623.
   PubMed Web of Science ®Google Scholar
• Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, et al. 2019. Pathologic prognostic factors in endometrial carcinoma (other than tumor type and grade). International Journal of Gynecological Pathology 38:S93–S113.
   PubMed Web of Science ®Google Scholar
• Stelloo E, Nout RA, Osse EM, Jürgenliemk-Schulz IJ, Jobsen JJ, Ludy Lutgens LC, et al. 2016. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clinical Cancer Research 22:4215–4224.
   PubMed Web of Science ®Google Scholar
• Soslow RA, Tornos C, Park KJ, Malpica A, Matias-Guiu X, Oliva E, et al. 2019. Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the international society of gynecological pathologists. International Journal of Gynecological Pathology 38:S64–S74.
   PubMed Web of Science ®Google Scholar
• Taneichi A, Fujiwara H, Takahashi Y, Takei Y, Machida S, Saga Y, et al. 2014. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma. International Journal of Gynecologic Cancer 24:1429–1433.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Viganò P, Somigliana E, Daguati R, Abbiati A, Fedele L. 2006. Adenomyosis: epidemiological factors. Best Practice & Research. Clinical Obstetrics & Gynaecology 20:465–477.
   PubMed Web of Science ®Google Scholar
• Whitney C, Spirtos NM. 2009. Gynecologic Oncology Group Surgical Procedures Manual. Available from: https://www.semanticscholar.org/paper/Gynecologic-Oncology-Group-Surgical-Procedures-Whitney-Spirtos/ef77d3d5e22d5515d42c9380df42ba6e0d409d54
   Google Scholar
• Zhang Z, Yang B, Zhang W, Gao X, Zhao C, Zhang X, et al. 2018. Clinicopathological characteristics and survival outcomes of patients with coexistence of adenomyosis and endometrial carcinoma. International Journal of Clinical and Experimental Pathology 11:956–962.
   PubMed Web of Science ®Google Scholar